Authors: | Nishihori, T.; Bashir, Q.; Pasquini, M. C.; Martens, M.; Wu, J.; Alsina, M.; Efebera, Y. A.; Gasparetto, C.; Geller, N.; Giralt, S.; Koreth, J.; McCarthy, P. L.; Scott, E. C.; Stadtmauer, E. A.; Vesole, D. H.; Hari, P. |
Abstract Title: | The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302) |
Meeting Title: | 2021 ASCO Annual Meeting |
Journal Title: | Journal of Clinical Oncology |
Volume: | 39 |
Issue: | 15 Suppl. |
Meeting Dates: | 2021 Jun 4-8 |
Meeting Location: | Virtual |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2021-05-20 |
Language: | English |
ACCESSION: | WOS:000708120604052 |
DOI: | 10.1200/JCO.2021.39.15_suppl.7003 |
PROVIDER: | wos |
Notes: | Meeting Abstract: 7003 -- Source: Wos |